Lynx Announces New Head of Board of Directors | GenomeWeb

NEW YORK, Jan 5 – Lynx Therapeutics announced Friday that Craig Taylor has been named chairman of its board of directors.

Taylor, who has been director of Lynx since March 1994, will take over from Sam Eletr. Eletr is is leaving the board but is expected to stay on as a consultant to the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.